Periodontitis is considered as an inflammatory disease caused by bacterial infection and characterized by loss of connective tissue and alveolar bone[@b1][@b2]. It is classified into two major types, namely chronic periodontitis (CP) and aggressive periodontitis (AgP)[@b3][@b4], and is generally regarded as one of the most common diseases around the world with a prevalence of 15--20%[@b5]. Of greater importance, periodontitis has been suggested to be associated with other disorders such as head and neck cancer, coronary heart disease, and chronic obstructive pulmonary disease[@b6][@b7][@b8][@b9]. Therefore, to elucidate the etiology, identify risk factors, and prevent its onset are very important. In the past few years, great efforts had been taken to elucidate potential background leading to the etiology of periodontitis. In addition to bacterial infection, individuals' susceptibility to periodontitis is likely to be of major importance in determining the manifestation and progression of the disease[@b10]. Genetic factors, such as cyclooxygenase-2 gene polymorphisms and interleukin gene polymorphisms had been demonstrated by meta-analyses that whether they were associated with periodontitis susceptibility[@b11][@b12][@b13][@b14][@b15][@b16].

Periodontal health needs a balance between tissue destruction enzymes, e.g. *matrix metalloproteinase* (MMP), and its inhibitors. The MMP is a family of proteolytic enzymes involved in matrix remodeling and basement membranes in the begging and developing course of a wide range of diseases[@b17]. In addition, it has been confirmed to be involved in the pathogenesis of periodontitis[@b18]. Many meta-analyses showed that *MMP*-1 1607 G1/G2 gene polymorphism was associated with CP susceptibility, as well with the severity of disease condition[@b19][@b20]. Regarding *MMP*-9-1562 C/T polymorphism, a meta-analysis indicated that it had no association with periodontitis[@b19], but another meta-analysis suggested that it might be involved in the development of periodontitis[@b21]. Therefore, we determined to perform a meta-analysis with improved quality and to investigate the interaction association between gene polymorphism and environmental factors such as smoking. Moreover, many molecular epidemiological studies has been conducted to investigate the association between *MMP*-3-1171 A5/A6, *MMP*-8-799 C/T, and *MMP*-2-753 C/T polymorphisms and periodontitis susceptibility. Nevertheless, the results still remain inconsistency and individual studies based on small sample sizes have low statistical power to investigate the real association[@b22]. These facts warranted us to perform a meta-analysis to further investigate the role of these polymorphisms in the pathogenesis of periodontitis.

Methods
=======

This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statementin reporting this meta-analysis[@b23].

Eligible criteria
-----------------

The following criteria were used for literature selection: 1) articles that explored the association between *MMP* gene polymorphisms and periodontitis (CP and/or AgP) susceptibility; 2) the study design was cohort or case-control study; 3) there are adequate data to estimate odds ratios (ORs) and corresponding 95% confidence intervals (CIs). Two investigators independently screened all papers by title or abstract and then by a full content evaluation. Any discrepancy between the two authors was solved by discussion with a third investigator.

Search strategy
---------------

A comprehensive electronic database search was conducted for studies that examined associations between *MMP* polymorphisms and periodontitis. We utilized the PubMed, Embase, and Web of Science citation index to identify papers in which *MMP* polymorphisms were examined in patients with periodontitis and controls (up to 20 September, 2015). In addition, bibliographies of all potentially relevant studies and recently reviews were reviewed to identify additional articles not indexed by the aforementioned databases. The following text words and MeSH terms were searched: "*matrix metalloproteinase*" (MeSH term and text word), "MMP" (text word), "genetic, polymorphism" (MeSH term), "polymorphism" (text word), "periodontal disease" (MeSH term and text word), and "periodontitis" (MeSH and text word). We limited the search to studies that were carried out on humans and were written in English.

Data extraction and quality assessment
--------------------------------------

Two authors independently extracted the data and assessed the methodological quality. The following data were extracted from each study: first author's surname, publication year, country, ethnicity, type of disease, source of control, sample size, number of genotype distribution, Hardy-Weinberg equilibrium (HWE) for controls, site of polymorphism, genotyping method, smoking percentile, and other factors for environment. Quality assessment of included studies was evaluated using the Newcastle-Ottawa scale (NOS) by two authors (*P* = 0.90 for κ test) independently[@b22].

Data Analysis
-------------

A *χ*^*2*^test was used to assess the deviation of genotype distribution from HWE among controls. We performed meta-analyses using allelic contrast, homozygote contrast, heterozygote contrast, recessive, and dominant models. The associations between the polymorphisms and periodontitis risk were assessed by ORs and corresponding 95% CIs. Cochran's *Q* metric was used to assess between tric was used to assess between-study heterogeneity. When the *Q* metric (*P* \< 0.1) indicated significant heterogeneity among studies, the random-effects model (the Der-Simonian and Laird method) was applied to perform the meta-analysis. If the between study heterogeneity was not significant (*P* ≥ 0.1), the fixed-effects model (Mantel-Haenszel method) was used. We quantified the degree of heterogeneity using *I*^2^ statistic[@b24]. *I*^2^ ranges between 0 and 100%, and stands for the proportion of inter-study variability attributable to heterogeneity rather than random error. *I*^2^ values of 75%, 50%, and 25% were defined as high, moderate, and low estimates, respectively. If the number of included studies was applicable, we conducted stratified analyses on the bias of type of disease, ethnicity, agreement with HWE for controls, source of control, severity of CP, smoking status, and genotyping method. Funnel plots are used to detect publication bias. In addition, we performed Egger's linear regression test to measure the asymmetry of funnel plot (*P* \< 0.05)[@b25]. The meta-analysis was conducted using the Stata 12.0 software (Stata Corp LP, College Station, TX, USA), and the *P* value was two-sided.

Results
=======

Study identification and characteristics
----------------------------------------

As shown in [Fig. 1](#f1){ref-type="fig"}, we initially identified 142 articles. Finally we included 16 articles[@b26][@b27][@b28][@b29][@b30][@b31][@b32][@b33][@b34][@b35][@b36][@b37][@b38][@b39][@b40][@b41] with 24 case-control studies involving 2,724 cases and 3,438 controls. Among them, there were four polymorphisms of *MMP* gene included in our meta-analysis: nine on *MMP*-9-1562 C/T, seven on *MMP*-3-1171 A5/A6, four on *MMP*-2-753C/T, and four on *MMP*-8-799 C/T. Two of these studies[@b28][@b37] contained data on two different groups (CP and AgP), which were considered independently. One article contained two independent case-control studies in different countries and in this study only allele number was available[@b39]. Three articles[@b27][@b40][@b41] were focused on two polymorphisms, and two articles[@b31][@b32] were focused on three polymorphisms, which were treated as independent case-control studies as well. Four articles with six case-control studies did not satisfy the HWE for control group[@b26][@b39][@b40][@b41]. Main characteristics of included studies were summarized in [Table 1](#t1){ref-type="table"}.

MMP-9-1562 C/T polymorphism and periodontitis susceptibility
------------------------------------------------------------

In all study subjects, meta-analysis showed a reduced risk between the *MMP*-9-1562 C/T polymorphism and periodontitis susceptibility in all tested genetic model (T vs. C: OR = 0.58, 95% CI = 0.37-0.90; TT vs. CC: OR = 0.17, 95% CI = 0.13--0.23; CT vs. CC: OR = 0.61, 95% CI = 0.41--0.93; TT + CT vs. CC: OR = 0.54, 95% CI = 0.32--0.93; TT vs. CC + CT: OR = 0.28, 95% CI = 0.21--0.36) with some evidence of between-study heterogeneity ([Table 2](#t2){ref-type="table"}, [Fig. 2](#f2){ref-type="fig"}). Sensitivity analysisby excluding studies with control inconsistent with HWE showed that the decreased risk was only observed in recessive model (OR = 0.41, 95% CI = 0.18--0.93). Stratification analysis by type of disease indicated that individuals were more susceptible to CP than AgP ([Table 2](#t2){ref-type="table"}).

MMP-3-1171 A5/A6 polymorphism and periodontitis susceptibility
--------------------------------------------------------------

Meta-analysis of the *MMP*-3-1171 A5/A6 polymorphism showed an elevated risk between the polymorphism and periodontitis susceptibility in three tested genetic model (A5 vs. A6: OR = 1.45, 95% CI = 1.26--1.66; A5/A5 vs. A6/A6: OR = 2.32, 95% CI = 1.42--3.81; A5/A5 vs. A6/A5 + A6/A6: OR = 2.03, 95% CI = 1.59--2.59) with low between-study heterogeneity ([Table 3](#t3){ref-type="table"}. Stratification by disease type indicated that individuals were more susceptible to CP rather than AgP ([Table 3](#t3){ref-type="table"}).

MMP-2-753C/T and MMP-8-799 C/T polymorphisms and periodontitis susceptibility
-----------------------------------------------------------------------------

Meta-analysis of the *MMP*-2-753 C/T showed no association between thepolymorphism and periodontitis susceptibility (T vs. C: OR = 1.13, 95% CI = 0.88--1.44; TT vs. CC: OR = 1.25, 95% CI = 0.58--2.73; CT vs. CC: OR = 1.14, 95% CI = 1.14, 95% CI = 0.85--1.53; CT + TT vs. CC: OR = 1.15, 95% CI = 0.87--1.53; TT vs. CC + CT: OR = 1.18, 95% CI = 0.55--2.56) with no between-study heterogeneity (*I*^2^ = 0% for all genetic models) ([Table 4](#t4){ref-type="table"}). The results of stratification analyses according to disease type, ethnicity, and smoking statuswere similar to the overall results ([Table 4](#t4){ref-type="table"}).

Meta-analysis of the *MMP*-8-799 C/T showed an increased risk between the polymorphism and periodontitis susceptibility in four genetic model (T vs. C: OR = 1.61, 95% CI = 1.11--2.35; TT vs. CC: OR = 2.26, 95% CI = 1.03--4.97; CT vs. CC: OR = 2.18, 95% CI = 1.19--4.00; CT + TT vs. CC: OR = 2.22, 95% CI = 1.21--4.08) with moderate to highbetween-study heterogeneity ([Table 4](#t4){ref-type="table"}). Subgroup analyses according to disease type, ethnicity, and smoking status showed that the increased risk was predominant in CP, Asians, and non-smokers ([Table 4](#t4){ref-type="table"}).

Publication bias
----------------

Due to limitations of the quantity of included studies, we just test the publication bias for *MMP*-9-1562 C/T and *MMP*-3-1171 A5/A6 polymorphisms. The funnel plots based on allele model for *MMP*-9-1562 C/T and *MMP*-3-1171 A5/A6 polymorphism were asymmetry and indicated that publication bias probably existed in the present study. The Egger's test showed there was some publication bias existed in the *MMP*-9-1562 C/T allele model ([Table 2](#t2){ref-type="table"}).

Discussion
==========

In the present meta-analysis, we aggregated data from published studies to estimate genetic associations between *MMP* gene, namely *MMP*-2-753 C/T, *MMP*-3-1171 A5/A6, *MMP*-8-799 C/T, and *MMP*-9-1562 C/T polymorphisms, and periodontitis susceptibility. Our results provided some evidence to support an elevated risk between periodontitis susceptibility and *MMP*-3-1171 A5 allele and *MMP*-8-799 T allele, and a reduced risk between periodontitis susceptibility and *MMP*-9-1562 T allele. But our study provided no evidence to support an association between *MMP*-2-753 C/T polymorphism and periodontitis. Appreciable differences were identified in the etiology characteristic between CP and AgP[@b42], indicating that there might be different genetic mechanism between them. In stratified analysis by disease type, their association with susceptibility of CP rather than AgP was observed. For *MMP*-9-1562 C/T polymorphism, we did not observe any meaningful associations in stratified analysis by ethnicity, severity of CP, and smoking status. The results were similar to *MMP*-3-1171 A5/A6 and *MMP*-2-753 C/T polymorphisms for periodontitis susceptibility. However, in stratified analysis by ethnicity and smoking status for *MMP*-8-799 C/T polymorphism indicated an elevated risk in Asian populations rather than Caucasian populations, and non-smokers rather than smokers.

To our knowledge, this is the first quantitative analysis that assessed the association between *MMP*-2-753 C/T, *MMP*-3-1171 A5/A6, and *MMP*-8-799 C/T polymorphisms and periodontitis susceptibility. With regard to *MMP*-9-1562 C/T polymorphism, two meta-analyses waspublished in 2013. *Pan et al.*[@b21] indicated that *MMP*-9-1562 C/T polymorphism might be involved in the development of periodontitis. However, *Song et al.*[@b19] suggested no association between *MMP*-9-1562 C/T polymorphism and periodontitis susceptibility. Compared with the previous meta-analyses, we had a lager sample size than them, which increased the statistical power, and we found a reduced risk of *MMP*-9-1562 T allele with periodontitis susceptibility. Genetic association researches designed to investigate relations between gene polymorphisms and complex outcomes must be interpreted with caution, because many factors could potentially affect the results. Therefore, we assessed the association with severity of CP and smoking status even though we did not observe any significant difference among the moderate and severe CP and no association among non-smokers. This might be caused by small sample size that only two studies[@b29][@b33] presented the association between polymorphism and disease severity, two studies[@b31][@b32] investigate the interaction between polymorphism and smoking status.

However, the present meta-analysis also has certain limitations that affect the interpretation of the results. First, the heterogeneity for *MMP*-9-1562 C/T polymorphism was high. Subgroup analyses suggested that the heterogeneity might come from the deviation of HWE, ethnicity, and genotyping method. Certainly, other clinical heterogeneity also might contribute to it, for instance different classification and diagnosis of periodontitis and differences on the oral examination by different clinicians. In addition, it is widely acknowledged that meta-analysis is a secondary analysis and we could not handle the problem of clinical heterogeneity in a meta-analysis. Therefore, we recommend that further studies should be designed as multi-center studies and utilizea unified criterion of disease. Second, although a comprehensive literature search was performed, it was likely that some publications were overlooked because of our language restriction for the literature search. In addition, the number of included studies for each polymorphism was limited. Therefore, the statistic power of present meta-analysis might be affected and the present results might be led to false positive or false negative rate. Third, we used genotype distributions and crude estimates of effect rather than adjusted estimates of association between polymorphism and periodontitis. Even though we investigated the interaction between polymorphism and disease severity and smoking status, the statistic power was limited due to most studies did not present the relevant data. Moreover, age, sex, and gene-gene interactions could not be assessed in our study due to insufficient data. Finally, the publication bias was of concern that small studies with negative results tend not to be published.

In conclusion, this meta-analysis with published data suggested that the *MMP*-2-753 C/T, *MMP*-3-1171 A5/A6, and *MMP*-9-1562 C/T polymorphisms were associated with periodontitis susceptibility and there is lack of association between the *MMP*-8-799 C/T polymorphism and periodontitis. Further studies with large sample size, gene-gene, and gene-environment detailed information are needed to validate the present results.
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###### Characteristics of the studies included in the meta-analysis.

  Polymorphism         Reference     Year   Country    Ethnicity   Disease type   Control source   Case    Control   Smoking (%)   Genotyping method   *P*^*\#*^ value   NOS score                                    
  ------------------ -------------- ------ ---------- ----------- -------------- ---------------- ------- --------- ------------- ------------------- ----------------- ----------- ------ ------ ---------- -------- ---
  MMP-9-1562 C/T        de Souza     2005    Brazil      Mixed          CP              HB          42       20           0               24                 13              1        0      0     PCR-RFLP    0.62    7
                         Holla       2006    Czech     Caucasian        CP              HB          122      43           4               93                 37              5       26.0   29.6     PCR       0.59    8
                         Keles       2006   Turkish    Caucasian        CP              HB          57       13           0               42                 24              4        NA     NA      PCR       0.82    7
                          Chen       2007    China       Asian         AgP              PB          62       15           2               101                26              1        NA     NA    PCR-RFLP    0.63    7
                         Gurkan      2007   Turkish    Caucasian       AgP              HB          58       53           1               78                 72              7       32.6   5.1      PCR       0.06    7
                         Gurkan      2008   Turkish    Caucasian        CP              PB          54       32           1               52                 52              3       47.1   3.7      PCR       0.02    6
                          Loo        2011    China       Asian          CP              PB          143      73          64               43                 72             135       NA     NA    PCR-RFLP   \<0.01   6
                      Isaza-Guzman   2011   Colombia     Mixed          CP              HB          58       11           0               47                  6              1       14.6   4.9    PCR-RFLP    0.16    7
                           Li        2012    China       Asian          CP              PB          68       26          28               99                 156            277      93.4   97.7   PCR-RFLP   \<0.01   6
  MMP-3-1171 A5/A6                                                                                 A5/A5    A5/A6       A6/A6            A5/A5              A5/A6          A6/A6                                        
                        Itagaki      2004    Japan       Asian         AgP              HB           0       17          20                4                 38             100       NA     NA     Taqman     0.87    8
                        Itagaki      2004    Japan       Asian          CP              HB           5       58          142               4                 38             100       NA     NA     Taqman     0.87    8
                        Astolfi      2006    Brazil      Mixed          CP              PB          19       52          19                8                 70             25        NA     NA    PCR-RFLP   \<0.01   6
                          Loo        2011    China       Asian          CP              PB          154      115         11               100                135            15        NA     NA    PCR-RFLP   \<0.01   6
                           Li        2012    China       Asian          CP              PB          75       44           3               213                283            36       93.4   97.7   PCR-RFLP   \<0.01   6
                        Letra\*      2012    Brazil      Mixed          CP              HB          NA       NA          NA               121                114            64        NA     NA     Taqman    \<0.01   6
                        Letra\*      2012      US      Caucasian        CP              HB          NA       NA          NA               51                 91             62        NA     NA     Taqman     0.13    7
  MMP-8-799C/T                                                                                      CC       CT          TT               CC                 CT             TT                                          
                          Chou       2011    China       Asian          CP              PB          122      191         48               53                 40             13       25.5   15.1   PCR-RFLP    0.22    8
                          Chou       2011    China       Asian         AgP              PB          34       50          12               53                 40             13        25    15.1   PCR-RFLP    0.22    7
                         Holla       2012    Czech     Caucasian        CP              HB          88       163         90               84                 134            60        30     28    PCR-RFLP    0.63    8
                        Emingil      2014    Turkey    Caucasian       AgP              PB          11       57          32               76                 66             25        29    3.6     TaqMan     0.10    8
  MMP-2-753C/T                                                                                      CC       CT          TT               CC                 CT             TT                                          
                         Holla       2005    Czech     Caucasian        CP              PB          107      38           4               93                 30              4        NA     NA    PCR-RFLP    0.42    8
                          Chen       2007    China       Asian         AgP              PB          63       15           1               98                 28              2        NA     NA    PCR-RFLP    1.00    7
                         Gurkan      2007   Turkish    Caucasian       AgP              HB          49       39           4               98                 54              5       32.6   5.1      PCR       0.06    7
                         Gurkan      2008   Turkish    Caucasian        CP              PB          51       32           4               67                 37              3       47.1   3.7      PCR       0.43    6

CP = chronic periodontitis, AgP = aggressive periodontitis, NA = not available, HB = hospital-based, PB = population-based.

*P*^\#^ for Hardy-Weinberg equilibrium, \*Only allele number available in controls.

###### Meta-analysis of the association between the MMP-9-1562 C/Tpolymorphism and periodontitis.

  Genetic Model and Subgroup     Subgroups    N   Test of Association   Test of Heterogeneity   *P*\* value                       
  ---------------------------- ------------- --- --------------------- ----------------------- ------------- --- --------- ------ -------
  T vs. C                         Overall     9          0.58                0.37--0.90            0.015      R   \<0.001   88.2   0.039
                                 HWE (yes)    6           0.8                0.64--1.00            0.052      F    0.198    31.6      
                                    AgP       2          0.93                0.67--1.29            0.656      F    0.496     0        
                                    CP        7          0.49                0.31--0.77            0.002      R   \<0.001   85.8      
                                 Caucasian    4          0.72                0.57--0.90            0.005      F    0.122    48.2      
                                   Asian      3          0.39                0.20--0.73            0.004      R   \<0.001   89.9      
                                   Mixed      2          0.89                0.49--1.59            0.684      F    0.596     0        
                                    HB        5          0.76                0.60--0.97            0.027      F    0.19     34.7      
                                    PB        4          0.44                0.25--0.79            0.006      R   \<0.001   89.7      
                                    PCR       4          0.72                0.57--0.90            0.005      F    0.122    48.2      
                                 PCR-RFLP     5          0.52                0.29--0.93            0.029      R   \<0.001   87.8      
                                Moderate CP   2          0.65                0.40--1.07            0.09       F    0.358     0        
                                 Sever CP     2          0.98                0.64--1.50            0.926      F    0.343     0        
                                Non-smokers   2          0.67                0.46--1.00            0.048      F    0.86      0        
  TT vs. CC                       Overall     9          0.17                0.13--0.23           \<0.001     F    0.217    25.6   0.121
                                 HWE (yes)    6           0.4                0.18--0.89            0.026      F    0.405    1.7       
                                    AgP       2          0.74                0.05--12.16           0.836      R    0.082    66.8      
                                    CP        7          0.16                0.12--0.22           \<0.001     F    0.564     0        
                                 Caucasian    4           0.3                0.12--0.76            0.011      F    0.578     0        
                                   Asian      3          0.18                0.09--0.38           \<0.001     R    0.043    68.1      
                                   Mixed      2          0.23                0.02--2.25            0.206      F    0.883     0        
                                    HB        5          0.29                0.12--0.72            0.008      F    0.718     0        
                                    PB        4          0.19                0.10--0.36           \<0.001     R    0.083     55       
                                    PCR       4           0.3                0.12--0.76            0.011      F    0.578     0        
                                 PCR-RFLP     5          0.16                0.11--0.22           \<0.001     F    0.171    37.6      
                                Moderate CP   2          0.34                0.06--2.08            0.245      F    0.831     0        
                                 Sever CP     2          0.75                0.20--2.81            0.667      F    0.563     0        
                                Non-smokers   2          1.38                0.38--4.92            0.623      F    0.579     0        
  CT vs. CC                       Overall     9          0.61                0.41--0.93            0.02       R   \<0.001   74.8   0.322
                                 HWE (yes)    6          0.87                0.66--1.14            0.293      F    0.406    1.6       
                                    AgP       2          0.97                0.65--1.46            0.896      F    0.906     0        
                                    CP        7          0.53                0.33--0.85            0.008      R    0.001    73.4      
                                 Caucasian    4          0.75                0.57--0.99            0.046      F    0.192    36.8      
                                   Asian      3          0.39                0.19--0.80            0.01       R    0.008    79.4      
                                   Mixed      2          1.09                0.56--2.11            0.808      F    0.453     0        
                                    HB        5          0.85                0.64--1.14            0.286      F    0.285    20.4      
                                    PB        4          0.43                0.25--0.76            0.004      R    0.007    75.3      
                                    PCR       4          0.75                0.57--0.99            0.046      F    0.192    36.8      
                                 PCR-RFLP     5          0.56                0.29--1.09            0.09       R    0.001    79.2      
                                Moderate CP   2           0.7                0.39--1.24            0.218      F    0.319     0        
                                 Sever CP     2          1.06                0.64--1.74            0.667      F    0.414     0        
                                Non-smokers   2            1                 0.63--1.57            0.988      F    0.51      0        
  TT + CT vs. CC                  Overall     9          0.54                0.32--0.93            0.025      R   \<0.001   86.9   0.104
                                 HWE (yes)    6          0.82                0.63--1.06            0.133      F    0.276    20.9      
                                    AgP       2          0.95                0.64--1.42            0.814      F    0.798     0        
                                    CP        7          0.46                0.26--0.82            0.009      R   \<0.001   85.8      
                                 Caucasian    4          0.71                0.54--0.93            0.013      F    0.134    46.2      
                                   Asian      3          0.32                0.13--0.77            0.011      R   \<0.001   89.9      
                                   Mixed      2          0.98                0.51--1.88            0.953      F    0.512     0        
                                    HB        5          0.79                0.59--1.04            0.098      F    0.21     31.7      
                                    PB        4          0.37                0.17--0.78            0.009      R   \<0.001   88.8      
                                    PCR       4          0.71                0.54--0.93            0.013      F    0.134    46.2      
                                 PCR-RFLP     5          0.48                0.22--1.07            0.072      R   \<0.001   88.6      
                                Moderate CP   2          0.65                0.37--1.14            0.132      F    0.323     0        
                                 Sever CP     2          1.02                0.63--1.66            0.939      F    0.363     0        
                                Non-smokers   2          1.02                0.66--1.58            0.935      F    0.439     0        
  TT vs. CC + CT                  Overall     9          0.28                0.21--0.36           \<0.001     F    0.601     0     0.379
                                 HWE (yes)    6          0.41                0.18--0.93            0.033      F    0.437     0        
                                    AgP       2          0.75                0.05--12.36           0.372      R    0.08     67.3      
                                    CP        7          0.27                0.20--0.35           \<0.001     F    0.897     0        
                                 Caucasian    4          0.33                0.13--0.83            0.018      F    0.624     0        
                                   Asian      3          0.27                0.21--0.36           \<0.001     F    0.119     53       
                                   Mixed      2          0.23                0.02--2.22            0.202      F    0.915     0        
                                    HB        5           0.3                0.12--0.75            0.01       F    0.753     0        
                                    PB        4          0.28                0.21--0.37           \<0.001     F    0.224    31.3      
                                    PCR       4          0.33                0.13--0.83            0.018      F    0.624     0        
                                 PCR-RFLP     5          0.27                0.21--0.36           \<0.001     F    0.368    6.7       
                                Moderate CP   2          0.37                0.06--2.26            0.284      F    0.891     0        
                                 Sever CP     2          0.73                0.20--2.72            0.64       F    0.618     0        
                                Non-smokers   2          1.35                0.38--4.80            0.641      F    0.618     0        

N = number of studies, OR = odds ratio, CI = confidence interval, F = fixed model, R = random model, CP = chronic periodontitis, AgP = aggressive periodontitis, HWE = Hardy-Weinberg equilibrium, HB = hospital-based, PB = population-based.

*P*\* value for publication bias (Egger's test).

###### Meta-analysis of the association between the MMP-3-1171 5A/6A polymorphism and periodontitis.

  Genetic Model and Subgroup    Subgroups   N   Test of Association   Test of Heterogeneity   *P*\* value                        
  ---------------------------- ----------- --- --------------------- ----------------------- ------------- ---- --------- ------ -------
  A5 vs. A6                      Overall    7          1.45                1.26--1.66           \<0.001     F     0.263    21.8   0.721
                                HWE (yes)   3          1.34                1.01--1.70            0.04       F     0.315    13.4      
                                   AgP      1          1.54                0.82--2.89            0.175      NA     NA       NA       
                                   CP       6          1.44                1.25--1.66           \<0.001     F     0.178    34.4      
                                Caucasian   1          1.55                1.05--2.30            0.029      NA     NA       NA       
                                  Asian     4          1.53                1.28--1.83           \<0.001     F     0.135     46       
                                Mixed^\#^   2          1.25                0.96--1.62            0.095      F     0.477     0        
                                   HB       4          1.25                1.02--1.54            0.033      F     0.444     0        
                                   PB       3          1.62                1.35--1.95           \<0.001     F     0.394     0        
                                 Taqman     4          1.25                1.02--1.54            0.033      F     0.444     0        
                                PCR-RFLP    3          1.62                1.35--1.95           \<0.001     F     0.394     0        
  A5/A5 vs. A6/A6                Overall    5          2.32                1.42--3.81            0.001      F     0.371    6.2    0.412
                                HWE (yes)   2           0.8                0.24--2.65            0.713      F     0.771     0        
                                   AgP      1          0.54                0.03--10.51           0.688      NA     NA       NA       
                                   CP       4          2.45                1.47--4.08            0.001      F     0.336    11.3      
                                  Asian     4          2.13                1.21--3.75            0.009      F     0.293    19.5      
                                Mixed^\#^   1          3.13                1.13--8.66            0.028      NA     NA       NA       
  A6/ A 5 vs. A6/A6              Overall    5          1.26                0.92--1.71            0.148      F     0.458     0     0.367
                                HWE (yes)   2          1.32                0.88--1.99            0.176      F     0.106    61.7      
                                   AgP      1          2.24                1.06--4.72            0.035      NA     NA       NA       
                                   CP       4          1.12                0.80--1.58            0.504      F     0.836     0        
                                  Asian     4          1.34                0.85--1.89            0.101      F     0.39     0.4       
                                Mixed^\#^   1          0.98                0.49--1.96            0.949      NA     NA       NA       
  (A5/A5 + A6/A5) vs. A6/A6      Overall    5          1.94                0.92--4.13            0.083      R    \<0.001   81.3   0.021
                                HWE (yes)   2          1.65                0.30--8.98            0.565      R    \<0.001   92.8      
                                   AgP      1          4.05                1.82--9.00            0.001      NA     NA       NA       
                                   CP       4          1.59                0.74--3.38            0.232      R     0.004    77.2      
                                  Asian     4          2.12                0.78--5.79            0.141      R    \<0.001   85.9      
                                Mixed^\#^   1          1.56                0.78--3.10            0.207      NA     NA       NA       
  A5/A5vs. (A6/A5 + A6/A6)       Overall    5          2.03                1.59--2.59           \<0.001     F     0.323    14.4   0.458
                                HWE (yes)   2          0.73                0.22--2.39            0.606      F     0.649     0        
                                   AgP      1          0.41                0.02--7.79            0.553      NA     NA       NA       
                                   CP       4          2.06                1.61--2.64           \<0.001     F     0.317    14.9      
                                  Asian     4          1.95                1.51--2.52           \<0.001     F     0.306     17       
                                Mixed^\#^   1          3.18                1.32--7.67            0.01       NA     NA       NA       

N = number of studies, OR = odds ratio, CI = confidence interval, F = fixed model, R = random model, CP = chronic periodontitis, AgP = aggressive periodontitis, HWE = Hardy-Weinberg equilibrium, HB = hospital-based, PB = population-based.

*P*\* value for publication bias (Egger's test), mixed^\#^ for ethnicity.

###### Meta-analysis of the association between the MMP-2-753C/T and MMP-8-799C/T polymorphisms and periodontitis.

  Genetic Model and Subgroup    N        T vs. C        TT vs. CC       CT vs. CC        (CT + TT) vs. CC    TT vs. (CC + CT)                                                           
  ---------------------------- --- ------------------- ----------- -------------------- ------------------ -------------------- ------ -------------------- ------ -------------------- ------
  MMP-2-753 C/T                                                                                                                                                                         
  Total                         4   1.13 (0.88--1.44)       0       1.25 (0.58--2.73)           0           1.14 (0.85--1.53)     0     1.15 (0.87--1.53)     0     1.18 (0.55--2.56)     0
   CP                           2   1.11 (0.79--1.55)       0       1.20 (0.43--3.37)           0           1.12 (0.74--1.68)     0     1.12 (0.76--1.66)     0     1.16 (0.42--3.24)     0
   AgP                          2   1.15 (0.81--1.64)     29.9      1.33 (0.41--4.31)           0           1.18 (0.77--1.79)    32.8   1.18 (0.78--1.78)    39.3   1.21 (0.38--3.88)     0
   Caucasian                    3   1.19 (0.91--1.55)       0       1.33 (0.58--3.03)           0           1.23 (0.89--1.69)     0     1.23 (0.90--1.69)     0     1.24 (0.55--2.80)     0
   Asian                        1   0.84 (0.45--1.58)      NA       0.78 (0.07--8.76)           NA          0.83 (0.41--1.68)     NA    0.83 (0.42--1.64)     NA    0.81 (0.07--9.06)     NA
   Non-smokers                  3   1.27 (0.92--1.75)       0       1.38 (0.52--3.62)           0           1.35 (0.91--2.00)     0     1.35 (0.92--1.97)     0     1.24 (0.48--3.22)     0
   Smokers                      1   0.85 (0.36--1.99)      NA       1.10 (0.09--13.00)          NA          0.73 (0.26--2.08)     NA    0.77 (0.28--2.10)     NA    1.21 (0.10--14.00)    NA
  MMP-8-799 C/T                                                                                                                                                                         
  Total                         4   1.61 (1.11--2.35)     81.6      2.26 (1.03--4.97)          80.8         2.18 (1.19--4.00)    81.5   2.22 (1.21--4.08)    94.5   1.44 (0.90--2.16)    47.3
   CP                           2   1.28 (1.07--1.54)       0       1.48 (1.02--2.15)           0           1.52 (0.86--2.69)     72    1.48 (1.13--1.95)    59.9   1.25 (0.90--1.73)     0
   AgP                          2   2.01 (0.98--4.11)     85.3      3.60 (0.61--21.33)         88.4         3.34 (1.11--10.04)   81.7   3.45 (0.95--12.55)   87.9   1.73 (0.68--4.42)    70.2
   Caucasian                    2   1.84 (0.78--4.32)     93.8      3.44 (0.58--20.47)         93.2         2.55 (0.51--12.76)   93.6   2.82 (0.53--14.96)   94.5   1.79 (0.89--3.61)     75
   Asian                        2   1.43 (1.11--1.85)       0       1.54 (0.89--2.67)           0           2.03 (1.40--2.93)     0     1.91 (1.35--2.70)     0     1.07 (0.64--1.79)     0
   Non-smokers                  4   1.79 (1.19--2.69)     79.4      2.88 (1.21--6.84)          78.3         2.37 (1.24--4.55)    77.2   2.52 (1.30--4.88)    80.5   1.64 (1.19--2.25)    38.7
   Smokers                      1   0.91 (0.58--1.42)      NA       0.81 (0.33--2.00)           NA          0.96 (0.46--1.99)     NA    0.91 (0.46--1.82)     NA    0.84 (0.39--1.81)     NA

OR = odds ratio, CI = confidence interval, CP = chronic periodontitis, AgP = aggressive periodontitis, NA = not available.

[^1]: These authors contributed equally to this work.
